Cawachi Limited (2664.T) operates a chain of drugstores primarily in Japan, retailing pharmaceuticals including cold medicines, gastrointestinal medicines, vitamins, eye drops, trauma medicines, health foods, nursing care products and dispensing products; cosmetics encompassing basic skin care, makeup and men's products; general merchandise such as hair care products, oral care items, detergents, papers, pet products and childcare products; and general food products like processed foods, daily items, sweets, beverages and alcohol. The company, founded in 1967 and headquartered in Oyama, Tochigi Prefecture, Japan, also engages in the insurance business and manages approximately 355 stores, many equipped with in-store dispensing pharmacies, targeting consumers in regions including Fukushima, Miyagi, Ibaraki, Tochigi, Gunma, Saitama, Chiba, Aomori and Iwate. In October 2025, Cawachi revised its full-year performance forecast upward alongside a dividend increase including a special 65th anniversary commemorative payout, following the release of interim results for the fiscal year ending March 2026; the company continues monthly sales updates and operational enhancements such as store refurbishments and extended hours amid a challenging consumer environment.